TR200001938T2 - AIDS tedavisi için kombinasyon terapisi. - Google Patents
AIDS tedavisi için kombinasyon terapisi.Info
- Publication number
- TR200001938T2 TR200001938T2 TR2000/01938T TR200001938T TR200001938T2 TR 200001938 T2 TR200001938 T2 TR 200001938T2 TR 2000/01938 T TR2000/01938 T TR 2000/01938T TR 200001938 T TR200001938 T TR 200001938T TR 200001938 T2 TR200001938 T2 TR 200001938T2
- Authority
- TR
- Turkey
- Prior art keywords
- reverse transcriptase
- hiv
- aids
- combination therapy
- antibiotics
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- AIDS & HIV (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
HIV proteaz inhibitörü bilesik A ile nükleosit ters transkriptaz inhibitörleri, nükleosit olmayan ters transkriptaz inhibitörleri veya proteaz inhibitörlerinin biri veya daha fazlasinin kombinasyonu, bilesikler, farmasötik olarak kabul edilebilir tuzlar veya esterler, farmasötik bilesim bilesenleri olarak, baska antiviraller, immünomodülatörler, antibiyotikler veya asilarla kombine olarak veya olmayarak HIV proteaz inhibisyonu, HIV ters transkriptaz inhibisyonu, AIDS' in önlenmesi veya tedavisi için yararlidir. AIDS tedavisi yöntemleri ve HIV enfeksiyonunu önleme veya tedavi etme yöntemleri de açiklanmaktadir.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6542197P | 1997-11-13 | 1997-11-13 | |
GBGB9807938.7A GB9807938D0 (en) | 1998-04-15 | 1998-04-15 | Combination therapy for the treatment of AIDS |
US9094098P | 1998-06-26 | 1998-06-26 | |
GBGB9819590.2A GB9819590D0 (en) | 1998-09-08 | 1998-09-08 | Combination therapy for the treatment of aids |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200001938T2 true TR200001938T2 (tr) | 2001-07-23 |
Family
ID=27451773
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2000/01938T TR200001938T2 (tr) | 1997-11-13 | 1998-11-12 | AIDS tedavisi için kombinasyon terapisi. |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP1044000B1 (tr) |
JP (1) | JP2001522889A (tr) |
KR (1) | KR20010032055A (tr) |
CN (1) | CN1285747A (tr) |
AR (1) | AR013758A1 (tr) |
AT (1) | ATE218866T1 (tr) |
AU (1) | AU749795B2 (tr) |
BG (1) | BG104507A (tr) |
BR (1) | BR9814146A (tr) |
CA (1) | CA2309164A1 (tr) |
CO (1) | CO4970782A1 (tr) |
DE (1) | DE69806062T2 (tr) |
EA (1) | EA200000513A1 (tr) |
ES (1) | ES2177103T3 (tr) |
HU (1) | HUP0100365A3 (tr) |
ID (1) | ID24922A (tr) |
IL (1) | IL135994A0 (tr) |
IS (1) | IS5481A (tr) |
NO (1) | NO20002481L (tr) |
PE (1) | PE20000020A1 (tr) |
PL (1) | PL340430A1 (tr) |
SK (1) | SK6842000A3 (tr) |
TR (1) | TR200001938T2 (tr) |
WO (1) | WO1999025352A1 (tr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9820417D0 (en) * | 1998-09-18 | 1998-11-11 | Glaxo Group Ltd | Antiviral combinations |
WO2003011221A2 (en) | 2001-07-30 | 2003-02-13 | University Of Southern California | PREPARATION AND USE OF α-KETO PHOSPHONATES |
KR20080032014A (ko) | 2003-01-14 | 2008-04-11 | 길리애드 사이언시즈, 인코포레이티드 | 복합 항바이러스 치료를 위한 조성물 및 방법 |
GB2400553A (en) * | 2003-04-14 | 2004-10-20 | Cipla Ltd | Antiviral pharmaceutical combination of lamivudine, stavudine and efavirenz, or derivatives thereof |
TWI375560B (en) | 2005-06-13 | 2012-11-01 | Gilead Sciences Inc | Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same |
TWI471145B (zh) | 2005-06-13 | 2015-02-01 | Bristol Myers Squibb & Gilead Sciences Llc | 單一式藥學劑量型 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2174921T3 (es) * | 1993-12-15 | 2002-11-16 | Merck & Co Inc | Inhibidores de la proteasa del vih. |
-
1998
- 1998-11-11 CO CO98066470A patent/CO4970782A1/es unknown
- 1998-11-12 AR ARP980105720A patent/AR013758A1/es unknown
- 1998-11-12 HU HU0100365A patent/HUP0100365A3/hu unknown
- 1998-11-12 ID IDW20000895A patent/ID24922A/id unknown
- 1998-11-12 BR BR9814146-5A patent/BR9814146A/pt not_active Application Discontinuation
- 1998-11-12 KR KR1020007005176A patent/KR20010032055A/ko not_active Application Discontinuation
- 1998-11-12 ES ES98959424T patent/ES2177103T3/es not_active Expired - Lifetime
- 1998-11-12 JP JP2000520785A patent/JP2001522889A/ja not_active Withdrawn
- 1998-11-12 EP EP98959424A patent/EP1044000B1/en not_active Expired - Lifetime
- 1998-11-12 CN CN98813077A patent/CN1285747A/zh active Pending
- 1998-11-12 WO PCT/US1998/024097 patent/WO1999025352A1/en not_active Application Discontinuation
- 1998-11-12 AT AT98959424T patent/ATE218866T1/de not_active IP Right Cessation
- 1998-11-12 CA CA002309164A patent/CA2309164A1/en not_active Abandoned
- 1998-11-12 PL PL98340430A patent/PL340430A1/xx unknown
- 1998-11-12 TR TR2000/01938T patent/TR200001938T2/tr unknown
- 1998-11-12 PE PE1998001094A patent/PE20000020A1/es not_active Application Discontinuation
- 1998-11-12 IL IL13599498A patent/IL135994A0/xx unknown
- 1998-11-12 DE DE69806062T patent/DE69806062T2/de not_active Expired - Fee Related
- 1998-11-12 EA EA200000513A patent/EA200000513A1/ru unknown
- 1998-11-12 AU AU15225/99A patent/AU749795B2/en not_active Ceased
- 1998-11-12 SK SK684-2000A patent/SK6842000A3/sk unknown
-
2000
- 2000-05-09 IS IS5481A patent/IS5481A/is unknown
- 2000-05-12 NO NO20002481A patent/NO20002481L/no not_active Application Discontinuation
- 2000-06-05 BG BG104507A patent/BG104507A/bg unknown
Also Published As
Publication number | Publication date |
---|---|
ID24922A (id) | 2000-08-31 |
PE20000020A1 (es) | 2000-01-27 |
IS5481A (is) | 2000-05-09 |
EA200000513A1 (ru) | 2000-10-30 |
BR9814146A (pt) | 2000-10-03 |
NO20002481D0 (no) | 2000-05-12 |
DE69806062T2 (de) | 2003-03-20 |
AU749795B2 (en) | 2002-07-04 |
AU1522599A (en) | 1999-06-07 |
CO4970782A1 (es) | 2000-11-07 |
SK6842000A3 (en) | 2000-12-11 |
JP2001522889A (ja) | 2001-11-20 |
IL135994A0 (en) | 2001-05-20 |
EP1044000A1 (en) | 2000-10-18 |
HUP0100365A3 (en) | 2002-06-28 |
ATE218866T1 (de) | 2002-06-15 |
WO1999025352A1 (en) | 1999-05-27 |
PL340430A1 (en) | 2001-02-12 |
DE69806062D1 (de) | 2002-07-18 |
BG104507A (bg) | 2001-03-30 |
AR013758A1 (es) | 2001-01-10 |
CA2309164A1 (en) | 1999-05-27 |
HUP0100365A2 (hu) | 2002-05-29 |
NO20002481L (no) | 2000-07-12 |
KR20010032055A (ko) | 2001-04-16 |
CN1285747A (zh) | 2001-02-28 |
EP1044000B1 (en) | 2002-06-12 |
ES2177103T3 (es) | 2002-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE377011T1 (de) | Gamma-hydroxy-2-(fluoralkylaminocarbonyl)-1- piperazinpentanamide als hiv-proteasehemmer | |
DE69228106D1 (de) | HIV-Protease-Inhibitoren | |
HK1049103A1 (zh) | 含有利托那韋(abt-538)並與茚地那韋(mk-639)結合藥物的組合物以及他們在治療艾滋病中的用途 | |
DE60218511D1 (de) | Dihydroxypyrimidin-carbonsäueramid-hemmer der hiv-integrase | |
MY109834A (en) | Benzoxazinones as inhibitors of hiv reverse transcriptase | |
ATE252081T1 (de) | Neue hiv-protease-inhibitoren | |
YU172991A (sh) | Sinergizam inhibitora hiv reverzne transkriptaze | |
BR9408305A (pt) | Composto composição farmacêutica processos para tratamento de aids e da infecção por hiv para preparação da infecção por hiv e para inibição de protease de hiv e combinação de compostos | |
ZA991029B (en) | Composition and methods for treatment of hiv infections. | |
BR0317095A (pt) | Uso de uma combinação contendo um inibidor da transcriptase reversa sem ser de nucleosìdeo (nnrti) com um inibidor citocromo p450, tal como inibidores da protease | |
TR200001938T2 (tr) | AIDS tedavisi için kombinasyon terapisi. | |
MX9705916A (es) | Terapia de combinacion para infeccion por vih usando el inhibidor de proteasa de vih indinavir y el inhibidor de transcriptasa inversa 3tc, opcionalmente junto con azt, ddi, o ddc. | |
MX9700036A (es) | Combinacion de compuestos, uso en la preparacion de composiciones para tratar infeccion por el vir s de inmunodeficiencia humana, y composiciones obtenidas. | |
FI970565A (fi) | HIV-proteaasia inhiboiva yhdistelmä | |
ECSP982741A (es) | Terapia combinada para el tratamiento del sida | |
KR970703770A (ko) | 사람 면역결핍 바이러스 감염에 대한 배합 치료(Combination therapy for HIV infection) | |
ECSP961660A (es) | Terapia combinada para infeccion por vih |